Dexmedetomidine decreases TLR4 expression to alleviate lung ischemia/reperfusion injury in mice
10.3969/j.issn.1001-6325.2018.07.013
- VernacularTitle:右美托咪定通过Toll样受体4减轻小鼠肺缺血/再灌注损伤
- Author:
Lei LIANG
1
;
Lin DENG
;
Mian XIE
;
Bo GUO
Author Information
1. 重庆市中医院 麻醉科
- Keywords:
dexmedetomidine;
lung ischemia/reperfusion;
TLR4;
inflammation cytokines
- From:
Basic & Clinical Medicine
2018;38(7):967-972
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the protective mechanism of dexmedetomidine ( Dex) hydrochloride to lung ischemia/reperfusion injury ( LIRI) in mice. Methods The wild type ( WT) and Toll-like receptor 4 knockout ( TLR4-/-) C57BL/6 Balb/c female mouse randomly divided into four groups: sham group ( S group) , pulmona-ry ischemia/reperfusion group ( I/R group) , normal saline group ( NS group) and Dex group ( D group) . In S group, the chest was opened only, but in I/R group, NS group and D group, model of lung ischemia/reperfusion injury in mice was made by clamping left pulmonary hilum for 30 min, and then reperfusion for 3 h. The lung tis-sue was observed by HE staining. RT-qPCR detected the expression of TLR4 mRNA, and ELISA measured the TNF-α, IL-6 and IL-1 levels, including WT and TLR4-/-. Western blot measured the expression of NLRP3 in lung tissue in both WT and TLR4-/-. Results Dex significantly decreased the pathological damage of LIRI, re-duced the expression of levels of TLR4 mRNA and the production of inflammatory cytokines ( P＜0.01) , and also suppress production and activation of NLRP3 ( P＜0.01) in lung ischemia/reperfusion tissue in WT mice. But no cytokines was found to be inhibited in TLR4-/- mice. Conclusions Dex may decrease the release of a variety of pro-inflammatory factors and inhibit production and activation of NLRP3 inflammasome by TLR4, thereby protect lung against LIRI.
